A randomized pilot study to compare hair follicle cell suspensions prepared using trypsin alone versus trypsin in combination with collagenase type I for transplantation in vitiligo
- PMID: 31361909
- DOI: 10.1111/ced.14061
A randomized pilot study to compare hair follicle cell suspensions prepared using trypsin alone versus trypsin in combination with collagenase type I for transplantation in vitiligo
Abstract
Background: Noncultured extracted hair follicle outer root sheath cell suspension (NC-EHF-ORS-CS) is an upcoming surgical technique to treat stable vitiligo. Conventionally it employs trypsin to tap the hair follicle (HF) reservoir for autologous melanocytes and their precursors for transplantation. However, a perifollicular dermal sheath composed of type 1 collagen encases the target 'bulge' region of the HF. Adding collagenase type 1 would digest the ORS, facilitating better release of cells.
Aim: To compare the repigmentation achieved using trypsin and a combination of collagenase plus trypsin, respectively, with dermabrasion alone, and to compare cell counts, viability and composition of both suspensions.
Methods: This was a randomized, double-blind, comparative, therapeutic trial, conducted as a pilot study on 22 patients with stable vitiligo. Three similar patches were randomized into three parallel treatment arms [(A) trypsin plus collagenase, (B) trypsin alone and (C) dermabrasion with vehicle alone]. Each patient's HF sample was divided and digested by the two methods, and transplanted as suspensions onto dermabraded patches, while a third dermabraded patch received the vehicle only. Suspensions were sent for laboratory analysis. Repigmentation was assessed over a follow-up of 6 months.
Results: There was a significant increase in cell yield and comparable viability when collagenase was added. Immunohistochemical and flow cytometry studies showed a nonsignificant increase in HMB45+ melanocytes and their precursor stem cells in group A. This trend was reflected clinically in the extent of repigmentation [group A (33.22%) > B (24.31%) > C (16.59%); P = 0.13]. Adding collagenase induced significantly higher repigmentation than dermabrasion alone (P < 0.05).
Conclusions: Incorporating collagenase type I into the conventional NC-EHF-ORS-CS technique resulted in enhanced retrieval of pigment-forming cells and subsequently improved repigmentation in vitiligo.
© 2019 British Association of Dermatologists.
Similar articles
-
Experimental study and clinical observations of autologous hair follicle cell transplants to treat stable vitiligo.Indian J Dermatol Venereol Leprol. 2020 Mar-Apr;86(2):124-133. doi: 10.4103/ijdvl.IJDVL_261_18. Indian J Dermatol Venereol Leprol. 2020. PMID: 31397397
-
Clinical and treatment characteristics determining therapeutic outcome in patients undergoing autologous non-cultured outer root sheath hair follicle cell suspension for treatment of stable vitiligo.J Eur Acad Dermatol Venereol. 2015 Jan;29(1):31-7. doi: 10.1111/jdv.12426. Epub 2014 Mar 14. J Eur Acad Dermatol Venereol. 2015. PMID: 24628828
-
Study of efficacy and safety of noncultured, extracted follicular outer root sheath cell suspension transplantation in the management of stable vitiligo.Int J Dermatol. 2018 Feb;57(2):245-249. doi: 10.1111/ijd.13759. Epub 2017 Oct 3. Int J Dermatol. 2018. PMID: 28971483
-
Repigmentation through Melanocyte Regeneration in Vitiligo.Dermatol Clin. 2017 Apr;35(2):205-218. doi: 10.1016/j.det.2016.11.015. Dermatol Clin. 2017. PMID: 28317529 Review.
-
Noncultured Epidermal Suspension in Vitiligo-A Review of Origins, Modifications, and Innovations for this Surgical Masterstroke!Skinmed. 2021 Dec 1;19(6):419-423. eCollection 2021. Skinmed. 2021. PMID: 35022112 Review.
Cited by
-
Race Reporting in Dermabrasion Clinical Trials: A Systematic Review.J Clin Aesthet Dermatol. 2025 Apr;18(4):28-32. J Clin Aesthet Dermatol. 2025. PMID: 40256334 Free PMC article. Review.
-
A Systematic Review of Case Series and Clinical Trials Investigating Regenerative Medicine for the Treatment of Vitiligo.J Cosmet Dermatol. 2025 Feb;24(2):e16660. doi: 10.1111/jocd.16660. Epub 2024 Nov 7. J Cosmet Dermatol. 2025. PMID: 39509558 Free PMC article.
-
Management of Stable Vitiligo-A Review of the Surgical Approach.J Clin Med. 2023 Mar 2;12(5):1984. doi: 10.3390/jcm12051984. J Clin Med. 2023. PMID: 36902772 Free PMC article. Review.
-
Management of the refractory vitiligo patient: current therapeutic strategies and future options.Front Immunol. 2024 Jan 4;14:1294919. doi: 10.3389/fimmu.2023.1294919. eCollection 2023. Front Immunol. 2024. PMID: 38239366 Free PMC article. Review.
-
Regenerative medicine in the treatment of specific dermatologic disorders: a systematic review of randomized controlled clinical trials.Stem Cell Res Ther. 2024 Jun 18;15(1):176. doi: 10.1186/s13287-024-03800-6. Stem Cell Res Ther. 2024. PMID: 38886861 Free PMC article.
References
-
- Goldsmith L, Fitzpatrick T. Fitzpatrick’s Dermatology in General Medicine. New York: McGraw-Hill Medical, 2012.
-
- Mohanty S, Kumar A, Dhawan J et al. Noncultured extracted hair follicle outer root sheath cell suspension for transplantation in vitiligo. Br J Dermatol 2011; 164: 1241-6.
-
- Kumar A, Mohanty S, Sahni K et al. Extracted hair follicle outer root sheath cell suspension for pigment cell restoration in vitiligo. J Cutan Aesthetic Surg 2013; 6: 121-5.
-
- Fein H, Maytin EV, Mutasim DF, Bailin PL. Topical protease therapy as a novel method of epidermal ablation: preliminary report. Dermatol Surg 2005; 31: 139-47.
-
- Chiu HC, Chang CH, Chen JS, Jee SH. Human hair follicle dermal papilla cell, dermal sheath cell and interstitial dermal fibroblast characteristics. J Formos Med Assoc Taiwan Yi Zhi 1996; 95: 667-74.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous